Bayview Pharmacy is pleased to present a specially compounded oral suspension that incorporates Sucralfate 5%, Lidocaine HCl 0.6%, Nystatin 30,000 Units/ml, Diphenhydramine HCl 0.05%, and Hydrocortisone 0.05%. This unique blend of medications is formulated to address a range of conditions, including but not limited to gastroesophageal reflux disease, ulcers, and oral candidiasis.

Sucralfate is an anti-ulcer medication that functions by creating a protective barrier over the ulcer, aiding in pain reduction and promoting healing. Lidocaine HCl is a local anesthetic that alleviates pain and discomfort associated with ulcers. Nystatin is an antifungal medication that is effective in treating oral candidiasis, a fungal infection of the mouth. Diphenhydramine HCl is an antihistamine that helps to mitigate inflammation and itching associated with oral candidiasis. Hydrocortisone is a corticosteroid that aids in reducing inflammation and itching associated with oral candidiasis.

This combination of medications is designed to provide symptomatic relief from gastroesophageal reflux disease, ulcers, and oral candidiasis. It is crucial to understand that this medication should only be used as directed by a healthcare provider. If you have any queries about this formulation or how it can assist in treating your condition, please do not hesitate to contact us at Bayview Pharmacy.

The oral suspension is a liquid dosage form in which the ingredients are uniformly dispersed throughout a liquid medium. This ensures a homogeneous mixture for administration, allowing for consistent dosing and optimal therapeutic effect. The liquid form also offers ease of swallowing, making it a suitable option for patients who may have difficulty swallowing solid dosage forms.

This compounded formulation of Sucralfate 5%/Lidocaine HCl 0.6%/Nystatin 30,000 Units/ml/Diphenhydramine HCl 0.05%/Hydrocortisone 0.05% Compound Oral Suspension is a liquid dosage form that provides a homogeneous mixture for administration. It is primarily used in the treatment of various oral conditions such as oral mucositis, aphthous ulcers, and oral candidiasis.

Patients with known hypersensitivity to any of the components of this formulation should refrain from using it. Special caution is advised for patients with a history of gastrointestinal obstruction, as the sucralfate component may exacerbate the condition.

It is crucial to be aware of potential drug interactions when using this formulation. Lidocaine HCl and Diphenhydramine HCl may interact with medications that affect the central nervous system, including benzodiazepines, barbiturates, and tricyclic antidepressants. Hydrocortisone may interact with medications that affect the endocrine system, such as estrogens, progestins, and androgens.

Adverse reactions associated with this formulation may include nausea, vomiting, and diarrhea. Allergic reactions such as rash, hives, and itching may also occur. If you experience any of these symptoms, it is recommended to seek medical attention immediately.

If you have any questions or concerns about this formulation, potential interactions, or adverse reactions, please do not hesitate to reach out for further information.

This compounded oral suspension formulation contains Sucralfate 5%, Lidocaine HCl 0.6%, Nystatin 30,000 Units/ml, Diphenhydramine HCl 0.05%, and Hydrocortisone 0.05%. It is specifically designed to address a range of conditions such as oral ulcers, mouth sores, and other inflammatory conditions affecting the mouth and throat. The unique combination of ingredients works synergistically to alleviate inflammation, manage pain, and foster healing.

Sucralfate, an anti-ulcer medication, functions by creating a protective barrier over the ulcer or sore, thereby reducing pain and facilitating healing. Lidocaine HCl, a local anesthetic, aids in minimizing pain and discomfort. Nystatin, an antifungal medication, is effective in treating fungal infections in the mouth and throat. Diphenhydramine HCl, an antihistamine, helps to mitigate inflammation and itching. Lastly, Hydrocortisone, a corticosteroid, is instrumental in reducing inflammation and swelling.

The administration of this formulation should be as per the directions provided by your healthcare provider. It is typically consumed orally, either in the form of a suspension or a tablet. It is crucial to adhere to the instructions on the label meticulously and to consume the medication as prescribed. If you have any queries regarding the administration of this medication, it is advisable to consult with your healthcare provider.

This compounded formulation of Sucralfate 5%/Lidocaine HCl 0.6%/Nystatin 30,000 Units/ml/Diphenhydramine HCl 0.05%/Hydrocortisone 0.05% Compound Oral Suspension is a versatile treatment option for a range of oral conditions. It is a liquid dosage form, where the ingredients are uniformly dispersed throughout a liquid medium, ensuring a homogeneous mixture for administration.

One of the primary uses of this formulation is for the treatment of oral mucositis, a condition that causes inflammation and ulceration of the mouth's mucous membranes. It is also effective in treating oral candidiasis, a fungal infection in the mouth caused by the yeast Candida albicans.

Additionally, this compound can be used to manage oral lichen planus, a chronic inflammatory condition affecting the mouth's mucous membranes. It is also beneficial for treating oral leukoplakia, characterized by white patches on the mouth's mucous membranes.

Lastly, this formulation can be used to treat oral submucous fibrosis, a condition that leads to the thickening and fibrosis of the mouth's mucous membranes. If you have any questions about using this formulation for any of these conditions, please consult with your healthcare provider.